HPS Pharmacies wish to give notice that InterPharma, in consultation with the Therapeutic Goods Administration (TGA), has initiated a drug quarantine for the 10mL and 30mL presentations of InterPharma Sodium Chloride 0.9% ampoules:

The following batches of 10mL ampoules are affected:

  • 2304400
  • 2301530
  • 2301531
  • 2207874

The following batches of 30mL ampoules are affected:

  • 2386043E
  • 2386048E
  • 2386051E
  • 2286030E

This urgent product quarantine has been initiated owing to possible contamination with Ralstonia pickettii. This is due to reported cases of R. pickettii in multiple jurisdictions. Whilst this has not yet been confirmed, as a precaution, products from the affected batches should be removed from use immediately and quarantined until further notice.

Please inspect your stock and quarantine all affected products. If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All affected products will be quarantined, and HPS Pharmacies will arrange for replacement stock as soon as possible. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact InterPharma on 1300 308 213 or your pharmacist at HPS Pharmacies.

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates